Insiders · Profile

Torti Frank

President and Vant Chair at Roivant Sciences · Director at Immunovant. Filing since 29 Sep 2022. CIK 0001647805

Company

Date

Role

Action

Amount

Of holding

23 Feb 2026

President and Vant Chair

Sold on a plan

587,390

$16.16M

4.1%

20 Feb 2026

President and Vant Chair

Sold on a plan

1,012,610

$27.49M

6.9%

19 Feb 2026

President and Vant Chair

Sold on a plan

1,400,000

$38.39M

9.2%

29 Sep 2022

Director

Bought

20,000

$116.20K

5.4%

4 decisions on file.